{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:45:45Z","timestamp":1792226745196,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41582-025-01140-4","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T12:03:41Z","timestamp":1758110621000},"page":"659-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The 2024 revisions of the McDonald criteria pose risk of multiple sclerosis overdiagnosis"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-1554","authenticated-orcid":false,"given":"Andrew J.","family":"Solomon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Brodersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"1140_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00270-4","author":"X Montalban","year":"2025","unstructured":"Montalban, X. et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(25)00270-4 (2025).","journal-title":"Lancet Neurol."},{"key":"1140_CR2","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1093\/brain\/awad073","volume":"146","author":"C Lebrun-Fr\u00e9nay","year":"2023","unstructured":"Lebrun-Fr\u00e9nay, C. et al. The radiologically isolated syndrome: revised diagnostic criteria. Brain 146, 3431\u20133443 (2023).","journal-title":"Brain"},{"key":"1140_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ebmed-2017-110886","volume":"23","author":"J Brodersen","year":"2018","unstructured":"Brodersen, J. et al. Overdiagnosis: what it is and what it isn\u2019t. BMJ Evid. Based Med. 23, 1\u20133 (2018).","journal-title":"BMJ Evid. Based Med."},{"key":"1140_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5694\/mja2.50455","volume":"212","author":"PP Glasziou","year":"2020","unstructured":"Glasziou, P. P., Jones, M. A., Pathirana, T., Barratt, A. L. & Bell, K. J. Estimating the magnitude of cancer overdiagnosis in Australia. Med. J. Aust. 212, 163\u2013168 (2020).","journal-title":"Med. J. Aust."},{"key":"1140_CR5","doi-asserted-by":"publisher","first-page":"h825","DOI":"10.1136\/bmj.h825","volume":"350","author":"M Johansson","year":"2015","unstructured":"Johansson, M., Hansson, A. & Brodersen, J. Estimating overdiagnosis in screening for abdominal aortic aneurysm: could a change in smoking habits and lowered aortic diameter tip the balance of screening towards harm? BMJ 350, h825 (2015).","journal-title":"BMJ"},{"key":"1140_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/jama.2020.26988","volume":"325","author":"AH Krist","year":"2021","unstructured":"Krist, A. H. et al. Screening for asymptomatic carotid artery stenosis: US Preventive Services Task Force recommendation statement. J. Am. Med. Assoc. 325, 476\u2013481 (2021).","journal-title":"J. Am. Med. Assoc."},{"key":"1140_CR7","doi-asserted-by":"publisher","first-page":"h2088","DOI":"10.1136\/bmj.h2088","volume":"350","author":"TL J\u00e4rvinen","year":"2015","unstructured":"J\u00e4rvinen, T. L. et al. Overdiagnosis of bone fragility in the quest to prevent hip fracture. BMJ 350, h2088 (2015).","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"1140_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.clineuro.2013.09.012","volume":"115","author":"A Siva","year":"2013","unstructured":"Siva, A. Asymptomatic MS. Clin. Neurol. Neurosurg. 115 (Suppl. 1), S1\u2013S5 (2013).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"1140_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S1474-4422(23)00281-8","volume":"22","author":"C Lebrun-Frenay","year":"2023","unstructured":"Lebrun-Frenay, C. et al. Radiologically isolated syndrome. Lancet Neurol. 22, 1075\u20131086 (2023).","journal-title":"Lancet Neurol."},{"key":"1140_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamaneurol.2016.5056","volume":"74","author":"Z Xia","year":"2017","unstructured":"Xia, Z. et al. Assessment of early evidence of multiple sclerosis in a prospective study of asymptomatic high-risk family members. JAMA Neurol. 74, 293\u2013300 (2017).","journal-title":"JAMA Neurol."},{"key":"1140_CR11","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1111\/ene.15849","volume":"30","author":"A Maunula","year":"2023","unstructured":"Maunula, A., Martola, J., Atula, S., Laakso, S. M. & Tienari, P. J. Incidental demyelination in magnetic resonance imaging and 10-year risk of multiple sclerosis: a data lake cohort study. Eur. J. Neurol. 30, 2376\u20132384 (2023).","journal-title":"Eur. J. Neurol."},{"key":"1140_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jamaneurol.2025.1481","volume":"82","author":"N Fissolo","year":"2025","unstructured":"Fissolo, N. et al. Prognostic factors for multiple sclerosis symptoms in radiologically isolated syndrome. JAMA Neurol. 82, 722\u2013733 (2025).","journal-title":"JAMA Neurol."},{"key":"1140_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/13524585251332115","volume":"31","author":"A Vilaseca","year":"2025","unstructured":"Vilaseca, A. et al. Radiologically isolated syndrome: how could we accurately diagnose a subclinical period of multiple sclerosis? Mult. Scler. 31, 771\u2013781 (2025).","journal-title":"Mult. Scler."},{"key":"1140_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/02813432.2020.1843826","volume":"38","author":"SB Nielsen","year":"2020","unstructured":"Nielsen, S. B., Spalletta, O., Toft Kristensen, M. A. & Brodersen, J. Psychosocial consequences of potential overdiagnosis in prostate cancer a qualitative interview study. Scand. J. Prim. Health Care 38, 439\u2013446 (2020).","journal-title":"Scand. J. Prim. Health Care"},{"key":"1140_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/0022146510386794","volume":"51","author":"S Timmermans","year":"2010","unstructured":"Timmermans, S. & Buchbinder, M. Patients-in-waiting: living between sickness and health in the genomics era. J. Health Soc. Behav. 51, 408\u2013423 (2010).","journal-title":"J. Health Soc. Behav."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01140-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:03:27Z","timestamp":1764248607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01140-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1038\/s41582-025-01140-4","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"17 September 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.J.S. has served as a consultant for Octave Bioscience, Kiniksa Pharmaceuticals and TG Therapeutics, served on advisory boards for TG Therapeutics, Horizon Therapeutics, Genentech\/Roche, Sanofi and Bristol Myers Squibb, provided non-promotional speaking for EMD Serono and Sanofi, was site principal investigator for contract research for Sanofi, Actelion, Genentech\/Roche and Novartis and received research funding from Bristol Myers Squibb. J.B.B. is a member of the board of Preventing Overdiagnosis; with international partners such as the\n                      British Medical Journal\n                      plus Dartmouth, Bond and Oxford Universities, it is based on a non-profit model.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}